TY - JOUR
T1 - Prophylactic use of the Angel® catheter in a patient with paraneoplastic syndrome scheduled for surgical tumor resection. A case report and literature review
AU - Stamenković, Dušica M.
AU - Nešković, Vojislava
AU - Marjanović, Ivan
AU - Tomić, Aleksandar
AU - Rusović, Siniša
AU - Marinković, Vlastimir
AU - Bančević, Vladimir
AU - Karanikolas, Menelaos
N1 - Funding Information:
Before the procedure, the patient was fully informed that theAngel® catheter is a new device that had not been extensively evaluated, and gave written informed consent. This work was supported solely by the Department funds.
Publisher Copyright:
© 2019 Inst. Sci. inf., Univ. Defence in Belgrade. All rights reserved.
PY - 2019
Y1 - 2019
N2 - Introduction: The Angel® catheter (BiO2 Medical Inc, San Antonio, Texas, USA) is a novel device that combines a triple lumen central venous catheter with an inferior vena cava filter for prevention of pulmonary embolism (IVC filter-catheter). Case report: We present the case of a 53-year-old male patient with renal carcinoma and a history of recent deep venous thrombosis (DVT) on oral anticoagulation who was scheduled to undergo open radical nephrectomy. Because of concerns about the risks from documented pre-existing DVT, we decided to insert the Angel® catheter preoperatively in order to have central venous access during surgery and also to reduce the risk of perioperative pulmonary embolism. On the first postoperative day, active gastric bleeding was detected and nadroparine was stopped. Before removal of the Angel® catheter, a pre-re-moval cavagram revealed large thrombus mass in the catheter filter. Because of the presence of the thrombus mass, the catheter was removed surgically, after a permanent vena cava filter was inserted. Conclusion: This case suggests that the use of the Angel® IVC filter/3-lumen central catheter combination could be a reasonable option for pulmonary embolism prophylaxis in the patients at a high risk for DVT, such as the patients with malignant disease, paraneoplastic syndrome and chemotherapy who need to undergo surgery.
AB - Introduction: The Angel® catheter (BiO2 Medical Inc, San Antonio, Texas, USA) is a novel device that combines a triple lumen central venous catheter with an inferior vena cava filter for prevention of pulmonary embolism (IVC filter-catheter). Case report: We present the case of a 53-year-old male patient with renal carcinoma and a history of recent deep venous thrombosis (DVT) on oral anticoagulation who was scheduled to undergo open radical nephrectomy. Because of concerns about the risks from documented pre-existing DVT, we decided to insert the Angel® catheter preoperatively in order to have central venous access during surgery and also to reduce the risk of perioperative pulmonary embolism. On the first postoperative day, active gastric bleeding was detected and nadroparine was stopped. Before removal of the Angel® catheter, a pre-re-moval cavagram revealed large thrombus mass in the catheter filter. Because of the presence of the thrombus mass, the catheter was removed surgically, after a permanent vena cava filter was inserted. Conclusion: This case suggests that the use of the Angel® IVC filter/3-lumen central catheter combination could be a reasonable option for pulmonary embolism prophylaxis in the patients at a high risk for DVT, such as the patients with malignant disease, paraneoplastic syndrome and chemotherapy who need to undergo surgery.
KW - Anticoagulants
KW - Central venous catheters
KW - Neoplasms
KW - Para neoplastic syndromes
KW - Pulmonary embolism
KW - Vena cava filters
KW - Venous thrombosis
UR - http://www.scopus.com/inward/record.url?scp=85079384744&partnerID=8YFLogxK
U2 - 10.2298/VSP170115133S
DO - 10.2298/VSP170115133S
M3 - Article
AN - SCOPUS:85079384744
SN - 0042-8450
VL - 76
SP - 648
EP - 652
JO - Vojnosanitetski Pregled
JF - Vojnosanitetski Pregled
IS - 6
ER -